Lv4
540 积分 2025-01-09 加入
Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial
16天前
已完结
World Health Organization Guideline on the Use and Indications of Glucagon-Like Peptide-1 Therapies for the Treatment of Obesity in Adults
16天前
已完结
Past history of obesity triggers persistent epigenetic changes in innate immunity and exacerbates neuroinflammation
16天前
已完结
Cardiometabolic parameter change by weight regain on tirzepatide withdrawal in adults with obesity: a post hoc analysis of the SURMOUNT-4 trial
16天前
已完结
Semaglutide and cardiovascular outcomes in obesity without diabetes
16天前
已完结
Tirzepatide for obesity treatment and diabetes prevention
16天前
已完结
Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial
16天前
已完结
1854-PUB: Benefits of Bariatric Surgery on Risk Cluster Assignment in Individuals at High Risk for Type 2 Diabetes
2个月前
已完结
Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study
2个月前
已完结
ldha induces beta cell dedifferentiation in diabetes through metabolic and epigenetic reprogramming
3个月前
已完结
皖公网安备34019202002308
